Anakinra utilization in refractory pediatric CAR T-cell associated toxicitiesCaroline Diorio, Nirali N. Shah, Anant Vatsayan et al.|Blood Advances|2022Cited by 56
Immune Reconstitution and Infection Patterns after Early Alemtuzumab and Reduced Intensity Transplantation for Nonmalignant Disorders in Pediatric PatientsSima Bhatt, Shalini Shenoy, Jeffrey J. Bednarski et al.|Transplantation and Cellular Therapy|2018Cited by 16
Immune Reconstitution Following Reduced Intensity Stem Cell Transplantation for Non-Malignant Disorders in ChildrenJeffrey J. Bednarski, Shalini Shenoy, Catherine T. Le et al.|Transplantation and Cellular Therapy|2013Cited by 1
Prevalence of and Risk Factors for Cardiac, Pulmonary, and Neurologic Dysfunction Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR StudyElizabeth Stenger, Allistair Abraham, Deepak Chellapandian et al.|Transplantation and Cellular Therapy|2022Cited by 1
Preservation of Pulmonary Function Following Hematopoietic Cell Transplant for Sickle Cell Disease: A STAR StudyFiona Horan, Elizabeth Stenger, Glenda N. Bendiak et al.|Transplantation and Cellular Therapy|2024Cited by 1